BDX
HealthcareBecton, Dickinson and Company
$159.66+0.03 (+0.02%)
Prev Close
$159.63
Open
$161.37
High
$162.41
Low
$159.12
Volume
1.51M
Market Cap
$57.83B
P/E
26.05
Div Yield
0.02%
Over the past 12 months, insider activity at Becton, Dickinson and Company (BDX) has been dominated by selling, with 1 insider purchase totaling $1.01M and 19 insider sales totaling $3.68M. The most recent insider transaction was by Feld Michael (officer: EVP, Chief Revenue Officer), who sold $13.6K worth of shares on Feb 27, 2026. Becton, Dickinson and Company operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $57.83B.
Buys (12M)
1
$1.01M
Sells (12M)
19
$3.68M
Net Activity
Net Seller
$2.67M
Active Insiders
7
last 12 mo
BDX Price Chart
BDX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026↗ | Feld Michael | officer: EVP, Chief Revenue Officer | Sell | 75 | $181.84 | $13.6K | 21,308 |
| Feb 18, 2026↗ | SCOTT BERTRAM L | Director | Sell | 1,906 | $182.61 | $348.1K | 36,763 |
| Jan 28, 2026↗ | Feld Michael | officer: EVP, CRO & Pres. Life Sciences | Sell | 75 | $202.73 | $15.2K | 16,431 |
| Jan 26, 2026↗ | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 75 | $202.73 | $15.2K | 0 |
| Jan 16, 2026↗ | Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | Sell | 1,610 | $207.46 | $334.0K | 13,105 |
| Jan 15, 2026↗ | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 4,064 | $208.39 | $846.9K | 0 |
| Dec 26, 2025↗ | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 74 | $196.08 | $14.5K | 0 |
| Dec 17, 2025↗ | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 629 | $196.03 | $123.3K | 0 |
| Dec 1, 2025↗ | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 75 | $193.36 | $14.5K | 0 |
| Nov 7, 2025↗ | SCOTT BERTRAM L | Director | Sell | 217 | $176.58 | $38.3K | 0 |
| Oct 28, 2025↗ | Feld Michael | EVP & President, Life Sciences | Sell | 57 | $186.01 | $10.6K | 0 |
| Sep 26, 2025↗ | Feld Michael | EVP & President, Life Sciences | Sell | 58 | $181.03 | $10.5K | 0 |
| Sep 11, 2025↗ | Fraser Claire | Director | Sell | 917 | $187.50 | $171.9K | 0 |
| Aug 22, 2025↗ | Feld Michael | EVP & President, Life Sciences | Sell | 57 | $197.99 | $11.3K | 0 |
| Aug 11, 2025↗ | HAYES GREGORY | Director | Buy | 5,250 | $191.57 | $1.01M | 0 |
| Aug 8, 2025↗ | Fraser Claire | Director | Sell | 863 | $192.30 | $166.0K | 0 |
| Jul 22, 2025↗ | Garrison Michael David | EVP & President, Medical | Sell | 6,360 | $180.29 | $1.15M | 0 |
| Jun 2, 2025↗ | Shan David | EVP and Chief ISC Officer | Sell | 1,166 | $171.19 | $199.6K | 0 |
| Apr 9, 2025↗ | Garrison Michael David | EVP & President, Medical | Sell | 479 | $197.28 | $94.5K | 0 |
| Mar 19, 2025↗ | Byrd Richard | EVP & President Interventional | Sell | 459 | $230.00 | $105.6K | 0 |
| Mar 12, 2025↗ | Byrd Richard | EVP & President Interventional | Sell | 1,940 | $224.91 | $436.3K | 0 |
| Feb 12, 2025↗ | SCOTT BERTRAM L | Director | Sell | 700 | $227.99 | $159.6K | 0 |
| Feb 10, 2025↗ | Henderson Jeffrey William | Director | Buy | 1,500 | $233.62 | $350.4K | 0 |
| Jan 21, 2025↗ | Neal Shana Carol | EVP and Chief People Officer | Sell | 787 | $240.00 | $188.9K | 0 |
| Jan 21, 2025↗ | Shan David | EVP and Chief ISC Officer | Sell | 500 | $240.00 | $120.0K | 0 |
| Jan 17, 2025↗ | Garrison Michael David | EVP & President, Medical | Sell | 597 | $236.51 | $141.2K | 0 |
| Dec 19, 2024↗ | Garrison Michael David | EVP & President, Medical | Sell | 2,838 | $223.33 | $633.8K | 0 |
| Dec 6, 2024↗ | Goette Roland | EVP and President, EMEA | Sell | 14,611 | $220.92 | $3.23M | 0 |
| Dec 6, 2024↗ | Neal Shana Carol | EVP and Chief People Officer | Sell | 1,000 | $220.49 | $220.5K | 0 |
| Dec 5, 2024↗ | Shan David | EVP and Chief ISC Officer | Sell | 1,500 | $220.25 | $330.4K | 0 |
| Aug 14, 2024↗ | Goette Roland | EVP and President EMEA | Sell | 4,018 | $234.08 | $940.5K | 0 |
| Jun 10, 2024↗ | Spoerel Thomas J | SVP,Controller&Chief Acct Off | Sell | 300 | $239.31 | $71.8K | 0 |
| May 15, 2024↗ | Goette Roland | EVP and President EMEA | Sell | 3,300 | $236.73 | $781.2K | 0 |
| May 13, 2024↗ | Goette Roland | EVP and President EMEA | Sell | 3,300 | $236.70 | $781.1K | 0 |
| Apr 30, 2024↗ | Garrison Michael David | EVP & President Medical | Sell | 1,715 | $232.81 | $399.3K | 0 |
| Mar 15, 2024↗ | Spoerel Thomas J | SVP,Controller&Chief Acct Off | Sell | 282 | $238.29 | $67.2K | 0 |
| Dec 11, 2023↗ | Garrison Michael David | EVP & President Medical | Sell | 1,239 | $232.46 | $288.0K | 0 |
| Nov 28, 2023↗ | Byrd Richard | EVP & President Interventional | Sell | 2,156 | $238.47 | $514.1K | 0 |
| Nov 16, 2023↗ | Goette Roland | EVP and President, EMEA | Sell | 1,751 | $235.07 | $411.6K | 0 |
| Sep 5, 2023↗ | Byrd Richard | EVP & President Interventional | Sell | 459 | $274.48 | $126.0K | 0 |
| Aug 28, 2023↗ | Fraser Claire | Director | Sell | 848 | $281.66 | $238.8K | 0 |
| Aug 11, 2023↗ | Hickey David | EVP & President, Life Sciences | Sell | 4,831 | $277.85 | $1.34M | 0 |
| Aug 8, 2023↗ | Garrison Michael David | EVP & President Medical | Sell | 1,300 | $277.13 | $360.3K | 0 |
| Feb 3, 2023↗ | Byrd Richard | EVP & President Interventional | Sell | 1,421 | $248.60 | $353.3K | 0 |
| Nov 18, 2022↗ | Neal Shana Carol | EVP and Chief People Officer | Sell | 788 | $235.00 | $185.2K | 0 |
| Nov 16, 2022↗ | Goette Roland | EVP and President, EMEA | Sell | 2,996 | $222.08 | $665.4K | 0 |
| Aug 15, 2022↗ | Hickey David | EVP & President, Life Sciences | Sell | 475 | $265.00 | $125.9K | 0 |
| Aug 15, 2022↗ | Polen Thomas E Jr | Chairman, CEO and President | Sell | 15,000 | $265.13 | $3.98M | 0 |
| Aug 9, 2022↗ | Khichi Samrat S. | EVP and General Counsel | Sell | 26,815 | $260.44 | $6.98M | 0 |
| Aug 9, 2022↗ | Polen Thomas E Jr | Executive Vice President | Sell | 3,825 | $260.00 | $994.5K | 0 |
| Jun 7, 2022↗ | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 1,026 | $260.00 | $266.8K | 0 |
| May 6, 2022↗ | Hickey David | EVP & President, Life Sciences | Sell | 475 | $256.00 | $121.6K | 0 |
| Feb 25, 2022↗ | Larson Betty D | EVP HR & CHRO | Sell | 46,658 | $271.90 | $12.69M | 0 |
| Feb 8, 2022↗ | Fraser Claire | Director | Sell | 841 | $271.70 | $228.5K | 0 |
| Feb 3, 2022↗ | Conroy Alexandre | EVP of Integrated Supply Chain | Sell | 12,787 | $270.16 | $3.45M | 0 |
| Dec 16, 2021↗ | Larson Betty D | EVP HR & CHRO | Sell | 3,682 | $255.00 | $938.9K | 0 |
| Dec 7, 2021↗ | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 233 | $250.00 | $58.3K | 0 |
| Nov 16, 2021↗ | Goette Roland | EVP and President, EMEA | Sell | 1,914 | $244.11 | $467.2K | 0 |
| Sep 8, 2021↗ | Hickey David | EVP & President, Life Sciences | Sell | 500 | $260.00 | $130.0K | 0 |
| Sep 8, 2021↗ | RIMEL REBECCA W | Director | Sell | 500 | $260.00 | $130.0K | 0 |
| Sep 8, 2021↗ | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 267 | $260.00 | $69.4K | 0 |
| Sep 3, 2021↗ | Lim James C | Executive Vice President | Sell | 14,584 | $257.44 | $3.75M | 0 |
| Sep 3, 2021↗ | RIMEL REBECCA W | Director | Sell | 500 | $257.10 | $128.6K | 0 |
| Sep 2, 2021↗ | RIMEL REBECCA W | Director | Sell | 244 | $254.00 | $62.0K | 0 |
| Aug 30, 2021↗ | RIMEL REBECCA W | Director | Sell | 207 | $252.00 | $52.2K | 0 |
| Aug 18, 2021↗ | Fraser Claire | Director | Sell | 387 | $251.58 | $97.4K | 0 |
| Aug 17, 2021↗ | RIMEL REBECCA W | Director | Sell | 207 | $252.00 | $52.2K | 0 |
| Aug 6, 2021↗ | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 266 | $242.30 | $64.5K | 0 |
| May 28, 2021↗ | Lim James C | Executive Vice President | Sell | 3,429 | $241.68 | $828.7K | 0 |
| May 27, 2021↗ | Fraser Claire | Director | Sell | 390 | $241.36 | $94.1K | 0 |
BDX Insider Buying Activity
The following table shows recent insider purchases of Becton, Dickinson and Company (BDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 11, 2025↗ | HAYES GREGORY | Director | Buy | 5,250 | $191.57 | $1.01M | 0 |
| Feb 10, 2025↗ | Henderson Jeffrey William | Director | Buy | 1,500 | $233.62 | $350.4K | 0 |
BDX Insider Selling Activity
The following table shows recent insider sales of Becton, Dickinson and Company (BDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026↗ | Feld Michael | officer: EVP, Chief Revenue Officer | Sell | 75 | $181.84 | $13.6K | 21,308 |
| Feb 18, 2026↗ | SCOTT BERTRAM L | Director | Sell | 1,906 | $182.61 | $348.1K | 36,763 |
| Jan 28, 2026↗ | Feld Michael | officer: EVP, CRO & Pres. Life Sciences | Sell | 75 | $202.73 | $15.2K | 16,431 |
| Jan 26, 2026↗ | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 75 | $202.73 | $15.2K | 0 |
| Jan 16, 2026↗ | Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | Sell | 1,610 | $207.46 | $334.0K | 13,105 |
| Jan 15, 2026↗ | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 4,064 | $208.39 | $846.9K | 0 |
| Dec 26, 2025↗ | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 74 | $196.08 | $14.5K | 0 |
| Dec 17, 2025↗ | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 629 | $196.03 | $123.3K | 0 |
| Dec 1, 2025↗ | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 75 | $193.36 | $14.5K | 0 |
| Nov 7, 2025↗ | SCOTT BERTRAM L | Director | Sell | 217 | $176.58 | $38.3K | 0 |
| Oct 28, 2025↗ | Feld Michael | EVP & President, Life Sciences | Sell | 57 | $186.01 | $10.6K | 0 |
| Sep 26, 2025↗ | Feld Michael | EVP & President, Life Sciences | Sell | 58 | $181.03 | $10.5K | 0 |
| Sep 11, 2025↗ | Fraser Claire | Director | Sell | 917 | $187.50 | $171.9K | 0 |
| Aug 22, 2025↗ | Feld Michael | EVP & President, Life Sciences | Sell | 57 | $197.99 | $11.3K | 0 |
| Aug 8, 2025↗ | Fraser Claire | Director | Sell | 863 | $192.30 | $166.0K | 0 |
| Jul 22, 2025↗ | Garrison Michael David | EVP & President, Medical | Sell | 6,360 | $180.29 | $1.15M | 0 |
| Jun 2, 2025↗ | Shan David | EVP and Chief ISC Officer | Sell | 1,166 | $171.19 | $199.6K | 0 |
| Apr 9, 2025↗ | Garrison Michael David | EVP & President, Medical | Sell | 479 | $197.28 | $94.5K | 0 |
| Mar 19, 2025↗ | Byrd Richard | EVP & President Interventional | Sell | 459 | $230.00 | $105.6K | 0 |
| Mar 12, 2025↗ | Byrd Richard | EVP & President Interventional | Sell | 1,940 | $224.91 | $436.3K | 0 |
| Feb 12, 2025↗ | SCOTT BERTRAM L | Director | Sell | 700 | $227.99 | $159.6K | 0 |
| Jan 21, 2025↗ | Neal Shana Carol | EVP and Chief People Officer | Sell | 787 | $240.00 | $188.9K | 0 |
| Jan 21, 2025↗ | Shan David | EVP and Chief ISC Officer | Sell | 500 | $240.00 | $120.0K | 0 |
| Jan 17, 2025↗ | Garrison Michael David | EVP & President, Medical | Sell | 597 | $236.51 | $141.2K | 0 |
| Dec 19, 2024↗ | Garrison Michael David | EVP & President, Medical | Sell | 2,838 | $223.33 | $633.8K | 0 |
| Dec 6, 2024↗ | Goette Roland | EVP and President, EMEA | Sell | 14,611 | $220.92 | $3.23M | 0 |
| Dec 6, 2024↗ | Neal Shana Carol | EVP and Chief People Officer | Sell | 1,000 | $220.49 | $220.5K | 0 |
| Dec 5, 2024↗ | Shan David | EVP and Chief ISC Officer | Sell | 1,500 | $220.25 | $330.4K | 0 |
| Aug 14, 2024↗ | Goette Roland | EVP and President EMEA | Sell | 4,018 | $234.08 | $940.5K | 0 |
| Jun 10, 2024↗ | Spoerel Thomas J | SVP,Controller&Chief Acct Off | Sell | 300 | $239.31 | $71.8K | 0 |
| May 15, 2024↗ | Goette Roland | EVP and President EMEA | Sell | 3,300 | $236.73 | $781.2K | 0 |
| May 13, 2024↗ | Goette Roland | EVP and President EMEA | Sell | 3,300 | $236.70 | $781.1K | 0 |
| Apr 30, 2024↗ | Garrison Michael David | EVP & President Medical | Sell | 1,715 | $232.81 | $399.3K | 0 |
| Mar 15, 2024↗ | Spoerel Thomas J | SVP,Controller&Chief Acct Off | Sell | 282 | $238.29 | $67.2K | 0 |
| Dec 11, 2023↗ | Garrison Michael David | EVP & President Medical | Sell | 1,239 | $232.46 | $288.0K | 0 |
| Nov 28, 2023↗ | Byrd Richard | EVP & President Interventional | Sell | 2,156 | $238.47 | $514.1K | 0 |
| Nov 16, 2023↗ | Goette Roland | EVP and President, EMEA | Sell | 1,751 | $235.07 | $411.6K | 0 |
| Sep 5, 2023↗ | Byrd Richard | EVP & President Interventional | Sell | 459 | $274.48 | $126.0K | 0 |
| Aug 28, 2023↗ | Fraser Claire | Director | Sell | 848 | $281.66 | $238.8K | 0 |
| Aug 11, 2023↗ | Hickey David | EVP & President, Life Sciences | Sell | 4,831 | $277.85 | $1.34M | 0 |
| Aug 8, 2023↗ | Garrison Michael David | EVP & President Medical | Sell | 1,300 | $277.13 | $360.3K | 0 |
| Feb 3, 2023↗ | Byrd Richard | EVP & President Interventional | Sell | 1,421 | $248.60 | $353.3K | 0 |
| Nov 18, 2022↗ | Neal Shana Carol | EVP and Chief People Officer | Sell | 788 | $235.00 | $185.2K | 0 |
| Nov 16, 2022↗ | Goette Roland | EVP and President, EMEA | Sell | 2,996 | $222.08 | $665.4K | 0 |
| Aug 15, 2022↗ | Hickey David | EVP & President, Life Sciences | Sell | 475 | $265.00 | $125.9K | 0 |
| Aug 15, 2022↗ | Polen Thomas E Jr | Chairman, CEO and President | Sell | 15,000 | $265.13 | $3.98M | 0 |
| Aug 9, 2022↗ | Khichi Samrat S. | EVP and General Counsel | Sell | 26,815 | $260.44 | $6.98M | 0 |
| Aug 9, 2022↗ | Polen Thomas E Jr | Executive Vice President | Sell | 3,825 | $260.00 | $994.5K | 0 |
| Jun 7, 2022↗ | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 1,026 | $260.00 | $266.8K | 0 |
| May 6, 2022↗ | Hickey David | EVP & President, Life Sciences | Sell | 475 | $256.00 | $121.6K | 0 |
| Feb 25, 2022↗ | Larson Betty D | EVP HR & CHRO | Sell | 46,658 | $271.90 | $12.69M | 0 |
| Feb 8, 2022↗ | Fraser Claire | Director | Sell | 841 | $271.70 | $228.5K | 0 |
| Feb 3, 2022↗ | Conroy Alexandre | EVP of Integrated Supply Chain | Sell | 12,787 | $270.16 | $3.45M | 0 |
| Dec 16, 2021↗ | Larson Betty D | EVP HR & CHRO | Sell | 3,682 | $255.00 | $938.9K | 0 |
| Dec 7, 2021↗ | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 233 | $250.00 | $58.3K | 0 |
| Nov 16, 2021↗ | Goette Roland | EVP and President, EMEA | Sell | 1,914 | $244.11 | $467.2K | 0 |
| Sep 8, 2021↗ | Hickey David | EVP & President, Life Sciences | Sell | 500 | $260.00 | $130.0K | 0 |
| Sep 8, 2021↗ | RIMEL REBECCA W | Director | Sell | 500 | $260.00 | $130.0K | 0 |
| Sep 8, 2021↗ | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 267 | $260.00 | $69.4K | 0 |
| Sep 3, 2021↗ | Lim James C | Executive Vice President | Sell | 14,584 | $257.44 | $3.75M | 0 |
| Sep 3, 2021↗ | RIMEL REBECCA W | Director | Sell | 500 | $257.10 | $128.6K | 0 |
| Sep 2, 2021↗ | RIMEL REBECCA W | Director | Sell | 244 | $254.00 | $62.0K | 0 |
| Aug 30, 2021↗ | RIMEL REBECCA W | Director | Sell | 207 | $252.00 | $52.2K | 0 |
| Aug 18, 2021↗ | Fraser Claire | Director | Sell | 387 | $251.58 | $97.4K | 0 |
| Aug 17, 2021↗ | RIMEL REBECCA W | Director | Sell | 207 | $252.00 | $52.2K | 0 |
| Aug 6, 2021↗ | Spoerel Thomas J | VP Controller & Chief Acct Off | Sell | 266 | $242.30 | $64.5K | 0 |
| May 28, 2021↗ | Lim James C | Executive Vice President | Sell | 3,429 | $241.68 | $828.7K | 0 |
| May 27, 2021↗ | Fraser Claire | Director | Sell | 390 | $241.36 | $94.1K | 0 |
BDX Insiders
Similar Stocks to BDX
ISRG
Intuitive Surgical, Inc.
$470.59-1.81%
$170.20B
RMD
ResMed Inc.
$231.35-0.45%
$33.92B
MDLN
Medline Inc.
$41.44+0.90%
$33.33B
WST
West Pharmaceutical Services, Inc.
$235.29+1.82%
$17.77B
HOLX
Hologic, Inc.
$75.11-0.13%
$16.84B
COO
The Cooper Companies, Inc.
$70.06-2.04%
$16.49B
MASI
Masimo Corporation
$175.50+0.00%
$9.42B
BAX
Baxter International Inc.
$17.45-3.11%
$8.95B